ADVFN US – Market Content Editor
-
U.S. Stocks Recover From Initial Pullback To Close Modestly Higher
Stocks moved to the downside at the start of trading on Monday but showed a notable recovery over the course of the session. The major averages climbed well off their lows of the session and into positive territory, with the Dow and the S&P 500 reaching new record closing highs. The major averages pulled back…
-
Gold Sets Fresh Record as Iran Unrest and Fed Pressure Drive Haven Demand
Gold prices surged to unprecedented levels on Monday, lifted by escalating political turmoil in Iran, rising pressure on the U.S. Federal Reserve, and softer-than-expected U.S. labor market data, all of which fueled demand for safe-haven assets. At 08:55 ET (13:55 GMT), spot gold was up 2.4% at $4,618.85 an ounce, after touching an all-time high…
-
Oil Prices Pause After Recent Rally as Iran Unrest and Venezuela Supply Outlook Offset Each Other
Oil prices traded in a narrow range on Monday following last week’s strong gains, as markets balanced the risk of supply disruptions linked to escalating protests in Iran against the possibility of additional supply returning from Venezuela. At 08:15 ET (13:15 GMT), Brent crude futures for March delivery were down 0.3% at $63.16 a barrel,…
-
Affirm Shares Gain as Trump’s Credit Card Rate Proposal Shifts Investor Focus
Shares of Affirm Holdings (NASDAQ:AFRM) climbed about 3% on Monday morning after U.S. President Donald Trump floated the idea of imposing a temporary cap on credit card interest rates. Trump said on his Truth Social platform that he wants to introduce a one-year ceiling of 10% on credit card interest rates starting January 20. The…
-
Atara Biotherapeutics Shares Sink After FDA Issues Rejection Letter
Shares of Atara Biotherapeutics (NASDAQ:ATRA) plunged about 55% on Monday after the U.S. Food and Drug Administration delivered a Complete Response Letter declining to approve the company’s cancer therapy submission. The FDA rejected EBVALLO (tabelecleucel), Atara’s treatment for Epstein-Barr virus–positive post-transplant lymphoproliferative disease (EBV+ PTLD) in patients who have previously received therapy. In its response,…
-
Duolingo Shares Slide After CFO Change and Q4 Update
Shares of Duolingo (NASDAQ:DUOL) dropped about 6.5% on Monday after the company announced a change in its finance leadership and shared preliminary results for the fourth quarter. The Pittsburgh-based language learning group said Gillian Munson will assume the role of Chief Financial Officer on February 23, 2026, succeeding Matt Skaruppa, who is stepping down after…
-
Stoke Therapeutics Shares Slide After Updated Phase 3 Timeline
Shares of Stoke Therapeutics (NASDAQ:STOK) fell about 18% after the company outlined revised timelines for its Phase 3 EMPEROR trial evaluating zorevunersen as a treatment for Dravet syndrome. The biotechnology company said it now expects to complete enrollment of 150 patients in the second quarter of 2026, with top-line data anticipated in mid-2027. Stoke also…
-
Day One Biopharmaceuticals Shares Surge on Robust 2025 Revenue Outlook
Shares of Day One Biopharmaceuticals (NASDAQ:DAWN) jumped about 19% on Monday morning after the company released preliminary figures showing strong revenue growth for 2025 driven by its lead product, OJEMDA. The biopharmaceutical group said preliminary 2025 U.S. net product revenue for OJEMDA reached $155.4 million, representing year-on-year growth of 172%. Alongside the update, Day One…
-
Planet Labs Shares Advance on Major Multi-Year Contract With Sweden
Planet Labs PBC (NYSE:PL) shares climbed around 5% on Monday after the Earth observation company disclosed a multi-year agreement with the Swedish Armed Forces valued in the low nine-figure range. Under the deal, Sweden will receive a comprehensive package of Planet’s satellite platforms, space-based data and situational awareness capabilities to support national defense, peacekeeping and…
-
Urban Outfitters Shares Slide Despite Record Holiday-Period Sales
Urban Outfitters (NASDAQ:URBN) shares fell about 7% on Monday morning, even after the retailer reported record holiday sales for the two months ended December 31, 2025. The lifestyle retail group, which operates brands including Anthropologie, Free People and Urban Outfitters, said total company net sales rose 9% compared with the same period in 2024. Net…